Enterprise League logo

Product

fetal hemoglobin induction therapies

BIOTECHNOLOGY

byIMMvention Therapeutix, Inc.

United States (US)

ABOUT THE PRODUCT

Research and development of therapies designed to induce fetal hemoglobin production, offering a potential treatment for sickle cell disease.

Information is owner-confirmed

Last updated 1 month ago

Price range
N/A

Other products/services from IMMvention Therapeutix, Inc.

Default Product Image
Bach1 Inhibitors
Biotechnology

N/A

IMMvention Therapeutix, Inc. Logo

IMMvention Therapeutix, Inc.

United States (US)